Radiopharmaceuticals Startup Secures $175M Funding
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
- Latest
- Trending
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
Biotech firm Eradivir raises $10.25M for Phase 2a EV25 study, aiming to revolutionize influenza treatment.
Health industry faces ongoing cyberattacks; federal response criticized for lack of funding and focus.
Ori Biotech and CRL partner to optimize CAR-T production, reducing labor by 70%, costs by 50%, and process time by ...
WebPT and Intel partner on AI motion capture for physical therapy, integrating RealSense technology into EMR for enhanced patient care.
Medera aims for Nasdaq listing via SPAC to boost gene therapies, spotlighting rare biotech SPACs in 2024.
ArsenalBio raises $325M to advance solid tumor CAR-T therapies. Focus on kidney, prostate cancer with innovative genomic technology.
Epic Systems introduces 100+ new AI features to enhance healthcare operations for doctors and patients.
Learn how investing £500 monthly can lead to a lifetime second income of £56,400 by smartly diversifying your portfolio.
Biotech sees stable funding as 2024 venture capital and IPOs rise. Investors focus on late-stage assets amid economic challenges.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.